Aggregates of luminescent silicon quantum dots (Si-QDs) selectively label certain organelles, such as lysosomes, endoplasmic reticulum, cytosol and nuclei, depending upon the size of the aggregates and their surface properties. We used Si-QDs in an aggregated form and the size of aggregates was controlled from ca. 30 to 270 nm diameter. In fixed human umbilical vein endothelial cells (HUVECs), allylamine-terminated Si-QDs selectively labeled cell nuclei, while Si-QDs, treated by the amphiphilic block copolymer Pluronic® F127, uniformly labeled cytosol. On the other hand, in live HUVECs, allylamine-modified Si-QDs selectively labeled lysosomes, whereas F127-treated Si-QDs showed size-dependent intracellular localization: F127-treated Si-QD aggregates with a small diameter of ca. 30 nm selectively labeled the endoplasmic reticulum and those with a large diameter of ca. 270 nm labeled lysosomes. Our results indicate that specific organelle imaging can be achieved by controlling the surface properties and size of Si-QD aggregates, without using conventional antigen–antibody reactions. Physicochemical interactions between silicon nanomaterials and cells play a critical role in the observed intracellular localization. The possible mechanism and cytotoxicity of the silicon nanomaterials are discussed.
No takes yet. Share an insight, caveat, or question.
Ohta et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: